AKT has been shown to promote cancer cell proliferation and survival by diverse mechanisms including the activation of downstream targets including forkhead transcription factors, GSK3, BAD, Bcl-XL, nuclear factor-kB, and mammalian target of rapamycin (mTOR) kinase [5], [6], [39], [40]. Here, MTOR is linked to cancer.